Your browser doesn't support javascript.
loading
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor­infiltrating CD68­positive cell counts in patients with EGFR­mutant non­small cell lung cancer.
Tsuda, Takeshi; Suzuki, Kensuke; Inomata, Minehiko; Hayashi, Kana; Mizushima, Isami; Tokui, Kotaro; Taka, Chihiro; Okazawa, Seisuke; Kambara, Kenta; Imanishi, Shingo; Miwa, Toshiro; Hayashi, Ryuji; Matsui, Shoko; Masaki, Yasuaki; Taniguchi, Hirokazu; Tobe, Kazuyuki.
Afiliación
  • Tsuda T; First Department of Internal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama 930-0194, Japan.
  • Suzuki K; Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Toyama 930-8550, Japan.
  • Inomata M; Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Toyama 930-8550, Japan.
  • Hayashi K; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Mizushima I; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Tokui K; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Taka C; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Okazawa S; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Kambara K; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Imanishi S; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Miwa T; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Hayashi R; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Matsui S; Department of Medical Oncology, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Masaki Y; First Department of Internal Medicine, Toyama University Hospital, Toyama, Toyama 930-0194, Japan.
  • Taniguchi H; Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Toyama 930-8550, Japan.
  • Tobe K; Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Toyama 930-8550, Japan.
Mol Clin Oncol ; 18(5): 38, 2023 May.
Article en En | MEDLINE | ID: mdl-37035471
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido